We have performed clinical evaluations of the following drugs with the
following sponsor companies:
| RESEARCH
CONTRACTS |
|
I. INDICATION: MAJOR DEPRESSIVE DISORDER |
|
| Drug |
# Of Studies |
Pivotal * |
Company |
|
| Bupropion |
3 |
* |
Burroughs
Wellcome |
|
| BW647 |
2 |
|
Burroughs
Wellcome |
|
| Oxaprotaline |
1 |
|
Ciba Geigy |
|
| Trazodone |
1 |
|
Mead Johnson |
|
| Adinazolam |
1 |
|
Upjohn |
|
| Fluoxetine |
1 |
|
Eli Lilly |
|
| Indalpine |
1 |
|
Rorer |
|
| Citalopram |
1 |
|
Pfizer |
|
| Citalopram |
1 |
* |
Lundbeck |
|
| Citalopram |
1 |
* |
Forest |
|
| Mianserin |
1 |
|
Organon |
|
| Etoperidone |
3 |
|
McNeil |
|
| Dothiepin |
1 |
|
Boots |
|
| Mirtazepine |
2 |
* |
Organon |
|
| Gepirone |
2 |
|
Bristol Meyers |
|
| Venlafaxine |
4 |
* |
Wyeth Ayerst |
|
| Venlafaxine ER |
2 |
* |
Wyeth Ayerst |
|
| Fluvoxamine |
2 |
|
Reid Rowell/
Solvay |
|
| MDL72394 |
1 |
|
Merrell Dow |
|
| Zalospirone |
1 |
|
Wyeth Ayerst |
|
| Ipsapirone |
1 |
|
Miles/Bayer |
|
| Ipsapirone ER |
2 |
|
Miles/Bayer |
|
| Sertraline |
3 |
* |
Pfizer |
|
| Paroxetine |
2 |
|
SmithKline
Beecham |
|
| Org4428 |
2 |
|
Organon |
|
| A75200 |
1 |
|
Abbott |
|
| Flesinoxan |
1 |
|
Solvay |
|
| CP93,393 |
1 |
|
Pfizer |
|
| L-754,030 (MK 0869) |
3 |
|
Merck |
|
| SR46349B |
1 |
|
Sanofi |
|
| Prozac SR |
1 |
|
Eli Lilly |
|
| Selegiline Patch |
2 |
|
Somerset |
|
| TAK #637-99-301 |
1 |
|
TAP |
|
NeuroSearch
#2389-002/003 |
2 |
|
NeuroSearch |
|
| SR3137 |
1 |
|
Sanofi |
|
| Otsuka 203 |
1 |
|
Otsuka |
|
| Lu 26054 (Escitalopram) |
1 |
|
Forest |
|
back to the top |
|
II. INDICATION: MANIA |
|
| Drug |
# Of Studies |
Pivotal * |
Company |
|
| BW234 |
1 |
|
Burroughs
Wellcome |
|
| Synthetic Salmon Calcitonin |
2 |
|
Armour |
|
| Ziprasidone |
1 |
|
Pfizer |
|
| Olanzapine |
1 |
|
Eli Lilly |
|
back to the top |
|
III. INDICATION:
GENERALIZED ANXIETY DISORDER |
|
| Drug |
# Of Studies |
Pivotal * |
Company |
|
| Alpidem |
1 |
|
Lorex |
|
| Gepirone |
1 |
|
Bristol-Meyers |
|
| Ipsapirone |
1 |
|
Miles/Bayer |
|
| Adinazolam SR |
1 |
|
Upjohn |
|
| Zalospirone |
1 |
|
Wyeth-Ayerst |
|
| Abecarnil |
2 |
|
Sandoz |
|
| LY237733 |
1 |
|
Eli Lilly |
|
| Buspar BID |
1 |
|
Bristol Meyers |
|
| DN2327 |
1 |
|
TAP |
|
| Adatanserin |
1 |
|
Wyeth-Ayerst |
|
| Venlafaxine ER |
1 |
* |
Wyeth-Ayerst |
|
| CP93,393 |
1 |
|
Pfizer |
|
| Flesinoxan |
1 |
|
Solvay |
|
| Paxil |
1 |
|
SmithKline Beecham |
|
Venlafaxine ER
(social phobia) |
1 |
|
Wyeth-Ayerst |
|
back to the top |
|
IV. INDICATION: PANIC DISORDER |
|
| Drug |
# Of Studies |
Pivotal * |
Company |
|
| Xanax SR |
1 |
|
Upjohn |
|
| Paroxetine |
1 |
* |
SmithKline
Beecham |
|
| Paroxetine CR |
1 |
|
SmithKline
Beecham |
|
| Sertraline |
1 |
* |
Pfizer |
|
| Pregabalin |
1 |
|
Parke-Davis |
|
|
Click here to return to the Rx page.
If you are age 18 or older and are interested in learning more about our
free programs, please call us at 770-333-0093.
Are you eligible?
info@carmanresearch.com
back to the top
About Us | What's
New | Facts | Clinical
Trial Process
Phases | Criteria | Depression | Anxiety | Panic Disorder
Bipolar Disorder | Social Phobia
| More Info | Rx
Carman Research is located in the Atlanta, Georgia area.
Carman Research
4015 South Cobb Drive
Suite 245
Smyrna, Georgia 30080
(770)333-0093 Phone
(770)432-2643 Fax
Copyright © 2000 Carman Research
Last modified: October 25, 2001
 |
